You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 104 No. 5, NOVEMBER 1959 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on HighWire
 •Citing articles on Web of Science (24)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Treatment of Pleural and Peritoneal Effusion with Intracavitary Colloidal Radiogold (Au 198)

JERZY DYBICKI, M.D.; OSCAR J. BALCHUM, M.D., Ph.D.; GEORGE R. MENEELY, M.D.

AMA Arch Intern Med. 1959;104(5):802-815.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

Therapy for recurrent effusions of the pleural and peritoneal cavities of patients with local or metastatic malignant processes is an important and often difficult clinical problem. Such effusions occur in at least 29% 1 of such patients, and, if recurrent and large, they can be the most significant factor in their management. Repeated withdrawals of abdominal and pleural fluid are not only trying to the patient but result in depletion of electrolytes and proteins. The intracavitary instillation of radioactive colloidal gold (Au198) is frequently of distinct benefit in slowing down or halting the accumulation of fluid, even though such therapy is not curative and does not abolish the malignant process.

An artificially induced radioactive isotope in colloid form was administered for therapeutic purposes for the first time in 1944, in Vanderbilt University Hospital. This was molecular iodine colloid made with cyclotron-produced I130 and prepared by Paul F. Hahn. . . . [Full Text PDF of this Article]


Author Affiliations

Nashville, Tenn.

Department of Medicine and the Radioisotope Center, Vanderbilt University School of Medicine.; Rockefeller Foundation Research Fellow, Gdansk, Poland (Dr. Dybicki). Assistant Professor of Medicine, University of Southern California School of Medicine, Los Angeles (Dr. Balchum). Associate Professor of Medicine and Director of the Radioisotope Center, Vanderbilt University School of Medicine and Hospital, Nashville, Tenn. (Dr. Meneely).


Footnotes

Submitted for publication June 5, 1959.

This work was supported in part by grants in aid of research from the American College of Chest Physicians, the Don Tobey Fund, the Fowler Fund, and Graduate Training Grant 2A5129, National Institute of Arthritis and Metabolic Diseases, Public Health Service.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1959 American Medical Association. All Rights Reserved.